Press Release
Category Added in a WPeMatico Campaign
-
Neurocrine Biosciences Provides Update on Phase 3 Study of Valbenazine in Dyskinetic Cerebral Palsy
SAN DIEGO, Dec. 22, 2025 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Phase 3 KINECT®-DCP study evaluating the…
Read More » -
ZIM Board Updates on Ongoing Strategic Review Process
HAIFA, Israel, Dec. 22, 2025 /PRNewswire/ — ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) (“ZIM” or the “Company”) today provided an…
Read More »


